Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
about
Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain)Effect of a Nurse-Led Psychoeducational Intervention on Healthcare Service Utilization Among Adults With Advanced Cancer.Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol.Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung CancerUtilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer.Early integration of palliative care services with standard oncology care for patients with advanced cancer.Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.Costs, Trends, and Related Factors in Treating Lung Cancer Patients in 67 Hospitals in Guangxi, China.Treatment Decisions for Babies with Trisomy 13 and 18.Estimated costs of advanced lung cancer care in a public reference hospital.Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden."Factors associated with non-small cell lung cancer treatment costs in a Brazilian public hospital".Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.Physician Agency and Patient Survival.Accuracy of administrative databases in detecting primary breast cancer diagnoses: a systematic review
P2860
Q33427359-EAF386FB-2B98-445B-8F38-101AE084934DQ35136490-ABC970AD-43C9-41E9-842B-EB1EAAEE1544Q35879797-06E21179-E744-4AD7-85B0-8EF55D5ECDDEQ35963416-E8C26E73-1427-433A-940D-C6E810FB8AC7Q36073707-BC732D42-431A-49AE-87F0-50110B3DEA81Q37350619-E6BBF76F-A066-4ADE-9BDF-4E16DC28DBC5Q38121761-805E9A69-175A-444D-BD19-7684A8EE3184Q38722972-B761E0C0-A6CB-4200-A499-36EE42B605CDQ38860831-AF5C7BA4-DDD9-45CB-9089-A84514996C30Q39213421-5763EFB4-6869-4064-B515-E1206C266348Q41434864-A3DD283E-64D1-47B9-98C3-3AD04137FF84Q47657310-FD5315F4-370D-408D-8187-A37256A68A3EQ49900846-89DE6ED4-FA97-467D-A77D-C23BF7CE15F4Q52681004-D48ACE1C-6E37-4EF0-A7A5-FC29C83FB0CCQ54106023-386EC1D5-F5EA-41AF-92E4-E95CCE802A94Q57109294-353DF288-9AE7-4848-8903-9F4757715BFB
P2860
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@ast
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@en
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@nl
type
label
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@ast
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@en
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@nl
prefLabel
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@ast
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@en
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@nl
P2093
P2860
P356
P1476
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.
@en
P2093
Andrew Glass
Beth Barber
Derek Weycker
Gerry Oster
Montserrat Vera-Llonch
Rohit Borker
P2860
P2888
P356
10.1186/1472-6963-11-305
P577
2011-11-10T00:00:00Z
P5875
P6179
1027515283